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TO THE EDITOR: The possible impact of
the Internet revolution has been much
discussed.1-3 In two surveys, conducted in
1999 and 2001, we surveyed oncology
patients from two teaching hospitals in
central Sydney to explore the experience
and impact of Internet use among Austral-
ian oncology patients.
In November 1999, a questionnaire was
mailed to 240 eligible patients selected from
617 sequential registrations to the oncology
units. Eligible patients were those who were
alive, competent, had cancer, were of
known address and whose attending medi-
cal officer was participating.
In the second survey, to obtain a more
representative sample, we invited all oncol-
ogy patients visiting the outpatient clinics
over a three-month period (September to
December 2001) to participate.
We received completed questionnaires
from 142 patients (response rate, 59%) in
1999 and from 153 patients (number of
refusals unknown) in 2001. Of these, 33%
(47/142) in 1999 and 46% (70/153) in
2001 had accessed the Internet for informa-
tion relating to their illness, either person-
ally or through family and friends. In both
surveys, most users accessed the Internet
from home, the information sought was
mainly in relation to treatment, and the
most-visited Internet sites were those of
cancer centres.
Patient perceptions of the impact of
Internet-acquired information on their
experience of cancer are summarised in the
Box. Most patients viewed its impact as
positive. The advantages of using the
Internet reported by patients included its
speed, convenience, privacy, currency,
diversity of viewpoints, and usefulness as a
support tool. Many reported that they had
sought corroboration of Internet informa-
tion with information from other sources,
especially their doctor. Problems identified
with the Internet were its impersonal
nature, time costs, overabundance of infor-
mation, and concerns about the discovery
of inappropriate, inaccurate or distressing
information. Most respondents emphasised
that they were able to recognise these
limitations, but, notwithstanding, consid-
ered the Internet a valuable resource. For
example, one respondent wrote: “I felt my
capacity to cope with the illness and
treatment greatly improved because I
learned enough from the Internet to
challenge my oncologist and thereby learn
to trust him and his advice.”
Despite concerns expressed by many
doctors, these oncology patients assessed
impacts as either positive or neutral in
overall influence. Increasing Internet use by
patients and their families should not be
viewed as a problem, but as an opportunity
for patients and their treatment teams to
work together, ensuring that patients have
up-to-date information about their illness
and its treatment and are aware that they
are not alone in the fight against cancer.
1. Van Der Weyden MB, Armstrong RM, Chew M. The
communication revolution: winners and losers [editorial].
Med J Aust 1999; 171: 512.
2. Coiera E. The Internet’s challenge to health care provision
[editorial]. BMJ 1996; 312: 3-4.
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TO THE EDITOR: We write to alert policy
makers and clinicians to the challenge
presented by rising cannabis use in north-
east Arnhem Land, in the Northern
Territory, given that many current cannabis
users were previously petrol sniffers. In the
past five years, there has been a rise in
cannabis use and evidence of expansion of
supply links in the Miwatj region.1 There
are concerns that rising cannabis use is
associated with social effects: increased
family violence, drug–alcohol psychosis,
self-harm and suicide, and community
disruption. Policy makers seeking to foster
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Perceived influence of Internet-acquired information among oncology patients 
in 1999 and 2001
Better No change Worse
Question not  
answered
1999 survey (n = 47)
Relationship with doctor 12 (26%) 30 (64%) 0 5 (11%)
Discussions with doctor 20 (43%) 22 (47%) 0 5 (11%)
Treatment decisions 22 (47%) 19 (40%) 1 (2%) 5 (11%)
Coping with illness 26 (55%) 15 (32%) 1 (2%) 5 (11%)
2001 survey (n = 70)
Relationship with doctor 24 (34%) 34 (49%) 2 (3%) 10 (14%)
Discussions with doctor 42 (60%) 18 (26%) 1 (1%) 9 (13%)
Treatment decisions 37 (53%) 25 (36%) 0 8 (11%)
Coping with illness 32 (46%) 31 (44%) 1 (1%) 6 (9%)
Current cannabis users among 
people aged 13–34 years in 
northeast Arnhem Land
Results for samples from two remote communities 
in the Miwatj region, assessed by using health 
worker consensus classification, self-report data, 
and supporting data from health clinic chart 
review.
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initiatives to minimise harmful outcomes
must develop general policies that can have
local effects in a varied Northern Territory
population. NT police have targeted canna-
bis in remote communities. A Substance
Abuse Select Committee and Illicit Drugs
Task Force, each with Indigenous represen-
tation, will report to the NT government
during 2002.
We recently began collecting baseline
data to allow us to evaluate the effects on
patterns of use of cannabis (and related
harm) of community-wide interventions.
These interventions will be similar to those
implemented for petrol sniffing,2 but with a
focus on improved availability of appropri-
ate drug education. We have selected a
random sample of about a third of the
residents (aged 13–34 years) from two
communities. From this sample, current
cannabis users (at least weekly) and past
petrol sniffers have been identified by using
health worker consensus classification, sup-
ported by data from review of the health
clinic chart and self-report, if available.
These data for 145 males and 141 females
are presented in the Figure. Among males
aged 20–34 years, 74% are current cannabis
users and, of these, 60% are former petrol
sniffers. To date, 57 cannabis users have
agreed to interview (34 males and 23
females) and, of these, 38 met DSM-IV
criteria for cannabis dependence.3
A particular health concern is that
persistent cannabis use may compound any
residual cognitive impairment from petrol
sniffing.
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TO THE EDITOR: In Australia, an estimated
11 000 people become infected with hepati-
tis C virus (HCV) each year.1 Most are
injecting drug users.
The Early Hepatitis C Intervention
Project was a collaboration between the
STD Services Surveillance Unit, Drug and
Alcohol Resource Unit and Infectious
Diseases Unit at the Royal Adelaide
Hospital, Adelaide, South Australia. Its
objectives were to manage people who had
seroconverted in the preceding 12 months
and to provide standard treatments for drug
use and dependence. Services included
information and education on HCV, refer-
ral, counselling, psychosocial support and
three-monthly clinical evaluation. The
project was approved by the Ethics Com-
mittee of the Royal Adelaide Hospital and
funded by the Department of Human
Services for 18 months.
The attendance rate was low. Of 88
people with HCV seroconversion who were
identified as eligible for enrolment by the
Surveillance Unit (from the mandatory
notification scheme), 57 agreed to further
contact by mail or telephone, and 12
attended for risk assessment. Of these, eight
enrolled in the project (10% of those
eligible).
Despite demographic variation within the
group, similarities included difficulties with
accommodation, finances, mental health
and social integration. Seven of the eight
participants had injecting drug use as the
risk factor for HCV infection. Most
participants also used alcohol and cannabis.
During the program, half decreased their
risk-taking behaviour: four reduced inject-
ing drug use, and four reduced alcohol use,
reaching low risk levels. Characteristics of
participants at their last interview are
summarised in the Box. Two participants
are maintaining regular contact with the
Drug and Alcohol Resource Unit.
Despite encouragement, few of the target
group engaged in the program. We do not
know why so few people who agreed to
attend a first appointment failed to do so.
We did not have their permission or the
resources to contact them again. Maintain-
ing contact with participants also proved
challenging, and was in part unsuccessful
because of complex, multifaceted social
issues aside from HCV infection (Box).
These included unstable accommodation,
use of health services only when in crisis,
mental health problems, financial difficul-
ties, polydrug use and continued risk-
taking behaviours despite harm-reduction
information.
In conclusion, the Australian epidemic of
HCV infection, driven by injecting drug
use, is likely to continue unless a new
approach to harm minimisation is devel-
oped. Such an approach will recognise that
comorbidities and social dislocation influ-
ence risk of infection. Unless treatment
programs address coexisting problems, it
will be futile to offer definitive treatment for
HCV infection.2
Within the limited objectives and
resources of this project, we were unable to
support these people comprehensively. We
believe that a “one-stop shop” that includes
active and intensive case management by a
flexible, multidisciplinary team and deals
with social, economic and mental health
Corrections
Re “Thiazolidinediones and type 2 
diabetes: new drugs for an old disease”, 
the New Drugs, Old Drugs article by 
Trisha M O’Moore-Sullivan and 
Johannes B Prins in the 15 April issue of 
the Journal (Med J Aust 2002; 176: 381-
386), in which an editing error resulted 
in the word “tryglyceride” replacing 
“total cholesterol”. Thus, on page 383, 
under the subheading “Both drugs 
increase HDL and LDL and decrease 
FFA levels; pioglitazone lowers 
triglyceride levels”, the first sentence in 
the second dot point should read 
“Rosiglitazone also tends to increase 
total cholesterol level and studies have 
reported variable effects on ratios of total 
cholesterol to high-density lipoprotein 
(HDL) and of LDL to HDL.” ❏
Re the article “The contribution of 
airway structure to early childhood 
asthma”, by McKay KO and Hogg JC, 
in the 16 September supplement to the 
Journal, Early childhood asthma: what we 
know and what we need to know (Med J 
Aust 2002; 177: S45-S47). The last two 
lines of the figure caption on page S46 
were omitted. The full caption should 
read:
“The vessels in the submucosa (a) are 
smaller than the vessels in the adventitia 
(c), and the vessels that pass through the 
muscle layer (b) connect them. These 
two sets of vessels are perfused in series, 
providing a basis for a difference in the 
nature of the inflammatory reaction in 
the submucosa and lumen compared 
with the peribronchiolar space.”
The article, with correct caption, 
appears on our website. ❏
